Biomedical

The basics of preclinical drug development for neurodegenerative disease indications

rnfinity

info@rnfinity.com

orcid logo

Karen L Steinmetz,

Karen L Steinmetz


Edward G Spack

Edward G Spack


  Peer Reviewed

copyright icon

© attribution CC-BY

  • 0

rating
78 Views

Added on

2024-11-10

Doi: http://dx.doi.org/10.1186/1471-2377-9-s1-s2
Related Subjects
Anatomy
Biochemistry
Epidemiology
Genetics
Neuroscience
Psychology
Oncology
Medicine
Musculoskeletal science
Pediatrics
Pathology
Pharmacology
Physiology
Psychiatry
Primary care
Women and reproductive health

Abstract

Related Subjects
Anatomy
Biochemistry
Epidemiology
Genetics
Neuroscience
Psychology
Oncology
Medicine
Musculoskeletal science
Pediatrics
Pathology
Pharmacology
Physiology
Psychiatry
Primary care
Women and reproductive health
copyright icon

© attribution CC-BY

  • 0

rating
78 Views

Added on

2024-11-10

Doi: http://dx.doi.org/10.1186/1471-2377-9-s1-s2
Related Subjects
Anatomy
Biochemistry
Epidemiology
Genetics
Neuroscience
Psychology
Oncology
Medicine
Musculoskeletal science
Pediatrics
Pathology
Pharmacology
Physiology
Psychiatry
Primary care
Women and reproductive health